Skip to main content
RPAY
NASDAQ Trade & Services

Activist Investor Veradace Capital Declares 8.6% Stake, Demands Board Changes at Repay Holdings

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Negative
Importance info
9
Price
$3.16
Mkt Cap
$275.486M
52W Low
$2.3
52W High
$6.055
52W Position info
37% above low
Off High info
48% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

RPAY sits 37% above its 52-week low of $2.3.

Summary

Activist investor Veradace Capital Management has filed a Schedule 13D, formally declaring an 8.6% stake in Repay Holdings Corp and demanding board changes and expressing concerns over the KUBRA acquisition.


Key Events · Ownership and Investor Activity · RPAY

  • Activist Stake Declared

    Veradace Capital Management LLC and its affiliates formally disclosed an 8.6% beneficial ownership stake in Repay Holdings Corp, representing a significant portion of the company's market capitalization.

  • Demands for Board Changes

    The activist investor is seeking the addition of two shareholder-supported directors to the Board of Directors to bring fresh perspectives on investor credibility, capital allocation, and value maximization.

  • Opposition to KUBRA Acquisition

    Veradace expressed concerns regarding the Issuer's performance over recent years and noted shareholder opposition to the KUBRA Data Transfer LTD acquisition.

  • Significant Investment

    The aggregate purchase price for the reported securities was approximately $31.3 million, indicating a substantial commitment by the activist investor.


Analysis · RPAY · Trade & Services

Veradace Capital Management LLC and its affiliates have formally declared an 8.6% activist stake in Repay Holdings Corp through this Schedule 13D filing. This marks a significant shift from a previously passive investment (13G filing) to an active intent to influence company strategy. The filing explicitly states Veradace's concerns regarding the Issuer's performance, shareholder opposition to the KUBRA acquisition, and the absence of shareholder perspective on the board. The activist group is demanding the addition of two shareholder-supported directors. This formal declaration, following recent news reports and the company's adoption of a poison pill, signals an escalating conflict between management and a major shareholder, potentially leading to a proxy fight or significant corporate changes. The aggregate investment of approximately $31.3 million underscores the seriousness of Veradace's campaign.

At the time of this filing, RPAY was trading at $3.16 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $275.5M. The 52-week trading range was $2.30 to $6.06. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RPAY - Latest Insights

RPAY
Jul 15, 2026, 5:00 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $4.09
Real-time Price: $3.80 info
Change: -$0.290 (-7%) info
Market Cap: $334.73M info
RPAY
Jul 14, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.98
Real-time Price: $3.80 info
Change: -$0.180 (-5%) info
Market Cap: $334.73M info
RPAY
Jul 13, 2026, 5:31 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $4.00
Real-time Price: $3.80 info
Change: -$0.200 (-5%) info
Market Cap: $334.73M info
RPAY
Jun 29, 2026, 1:28 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $4.30
Real-time Price: $3.80 info
Change: -$0.495 (-12%) info
Market Cap: $334.73M info
RPAY
Jun 29, 2026, 8:39 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $3.99
Real-time Price: $3.80 info
Change: -$0.190 (-5%) info
Market Cap: $334.73M info